Whalegun
Home

Neurocrine Biosciences NBIX spent $890K on lobbying in Q2 2025 · Medicare, Health Issues and 2 more issues

Trade details

Type
Lobbying report
Amount
$890,000
Quarter
Q2 2025
Stock
Neurocrine Biosciences NBIX
Client
Neurocrine Biosciences
Reported
25/07/21

Down 2.2% from last quarter

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 25/05/31~25/07/30

Neurocrine Biosciences's other lobbying reports

Neurocrine Biosciences NBIX spent $890K on lobbying in Q2 2025 · Medicare, Health Issues and 2 more issues | Whalegun